- Home
- PRTA vs SEDG Comparison
PRTA vs SEDG Comparison
Compare PRTA & SEDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- SEDG
- Stock Information
- Founded
- PRTA 2012
- SEDG 2006
- Country
- PRTA Ireland
- SEDG Israel
- Employees
- PRTA N/A
- SEDG N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- SEDG Semiconductors
- Sector
- PRTA Health Care
- SEDG Technology
- Exchange
- PRTA Nasdaq
- SEDG Nasdaq
- Market Cap
- PRTA 765.2M
- SEDG 770.2M
- IPO Year
- PRTA N/A
- SEDG 2015
- Fundamental
- Price
- PRTA $15.56
- SEDG $17.62
- Analyst Decision
- PRTA Buy
- SEDG Hold
- Analyst Count
- PRTA 8
- SEDG 27
- Target Price
- PRTA $46.00
- SEDG $26.45
- AVG Volume (30 Days)
- PRTA 336.3K
- SEDG 5.1M
- Earning Date
- PRTA 02-20-2025
- SEDG 02-19-2025
- Dividend Yield
- PRTA N/A
- SEDG N/A
- EPS Growth
- PRTA N/A
- SEDG N/A
- EPS
- PRTA N/A
- SEDG N/A
- Revenue
- PRTA $135,157,000.00
- SEDG $901,456,000.00
- Revenue This Year
- PRTA $56.89
- SEDG $25.57
- Revenue Next Year
- PRTA N/A
- SEDG $35.25
- P/E Ratio
- PRTA N/A
- SEDG N/A
- Revenue Growth
- PRTA 47.92
- SEDG N/A
- 52 Week Low
- PRTA $11.70
- SEDG $10.24
- 52 Week High
- PRTA $31.03
- SEDG $78.41
- Technical
- Relative Strength Index (RSI)
- PRTA 59.65
- SEDG 61.46
- Support Level
- PRTA $13.69
- SEDG $12.95
- Resistance Level
- PRTA $15.09
- SEDG $23.77
- Average True Range (ATR)
- PRTA 0.91
- SEDG 1.50
- MACD
- PRTA 0.13
- SEDG 0.51
- Stochastic Oscillator
- PRTA 68.56
- SEDG 46.24
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.